Glancy prongay & murray llp, a leading securities fraud law firm, announces the filing of a securities class action on behalf of ampio pharmaceuticals, inc. (ampe) investors

Los angeles--(business wire)--glancy prongay & murray llp (“gpm”), a leading national shareholder rights law firm, announces that a class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired ampio pharmaceuticals, inc. (“ampio” or the “company”) (nyse: ampe) common stock between december 29, 2020 and august 3, 2022, inclusive (the “class period”). ampio investors have until october 17, 2022 to file a lead plaintiff motion. if you suffered a loss on your a
AMPE Ratings Summary
AMPE Quant Ranking